购物车摘要

购物车里还没有商品。

Rosuvastatin calcium

SKU: orb1226214

描述

A potent, competitive inhibitor of HMG-CoA reductase (HMGCR) with IC50 of 11 nM; potently inhibits cholesterol biosynthesis (IC50=1.12 nM) in rat isolated hepatocytes, 100 times more potent than pravastatin; also exerts important anti-inflammatory effects via inhibition of endothelial cell adhesion molecule expression.Dyslipidemia Approved(In Vivo):Rosuvastatin Calcium (10 mg/kg, intraperitoneal) prolonges QTc in conscious and unrestraines guinea pigs from 201±1 to 210±2 ms.Rosuvastatin (20 mg/kg/day, for 2 weeks) significantly reduces very low-density lipoproteins Calcium (VLDL) in diabetes mellitus rats induced by Streptozocin.

研究领域

Pharmacology & Drug Discovery

图片与验证

−

关键属性

−
CAS 号147098-20-2
MW500.57
纯度>98% (HPLC)
分子式C22H27Ca0.5FN3O6S
SMILESCC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.[Ca+2]
靶点HMGCR
溶解性10 mM in DMSO

生物活性

−
体内
Rosuvastatin Calcium (10 mg/kg, intraperitoneal) prolonges QTc in conscious and unrestraines guinea pigs from 201±1 to 210±2 ms. Rosuvastatin (20 mg/kg/day, for 2 weeks) significantly reduces very low-density lipoproteins Calcium (VLDL) in diabetes mellitus rats induced by Streptozocin.

储存与操作

−
储存Storage temperature: -20°C. Stability: ≥ 2 years
有效期12 months from date of receipt.
免责声明For research use only

别名

−
ZD-4522 calcium

相似产品

−
质量保证

质量保证

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our 条款与条件和选购指南.

实验方案信息

可选规格

请在下方选择规格

50 mg
¥ 1,170.00
100 mg
¥ 1,950.00
200 mg
¥ 2,860.00
500 mg
¥ 4,550.00